Fetal support tissue products and methods of use
Methods of treating a complex wound by administering to a complex wound in the individual a therapeutically effective amount of a fetal support tissue product to treat the complex wound. Methods of treating a complex lower extremity ulcer by administering to a complex lower extremity ulcer in the individual a therapeutically effective amount of a fetal support tissue product to treat the complex lower extremity ulcer. Methods of reducing or preventing scar formation from granulation tissue by administering a fetal support tissue product to granulation tissue. Methods of repairing a spina bifida defect by administering to the defect in the individual a therapeutically effective amount of an umbilical cord product.
1. A method of treating a complex wound in an individual in need thereof, comprising: administering to a complex wound in the individual in need thereof, a therapeutically effective amount of a fetal support tissue product comprising previously frozen umbilical cord amniotic membrane, wherein the fetal support tissue product is formulated as an allograft from which water has not been substantially removed, wherein the complex wound comprises a wound that is characterized by exposed bone, muscle, tendon, joint capsule, or a combination thereof, wherein the complex wound is re-vascularized and re-epithelialized by the fetal support tissue product.
2. The method of claim 1 , wherein the complex wound is an ulcer, a lower extremity ulcer, a foot ulcer, a chronic foot ulcer, a pressure sore, a diabetic foot ulcer, or an ischemic wound, a neurotropic ulcer, an arterial ulcer, or combination thereof.
3. The method of claim 1 , wherein the complex wound comprises exposed bone.
4. The method of claim 3 , wherein the complex wound comprises bone loss.
5. The method of claim 1 , further comprising debriding the complex wound, wherein the debriding is surgical debridement.
6. The method of claim 1 , further comprising resecting bone wherein the resecting is performed until healthy bone is reached, and further, wherein the resecting is performed to substantially remove necrotic or diseased bone.
7. The method of claim 1 , further comprising opening the cortex of exposed bone.
8. The method of claim 1 , further comprising covering the fetal support tissue product with a dressing, antimicrobial dressing, antimicrobial alginate dressing, compression dressing, gauze, patch, substrate, backing, covering, bandage, or a combination thereof.
9. The method of claim 1 , further comprising administering a treatment selected from the group consisting of antibiotics, hyperbaric oxygen therapy, revascularization therapy, and combinations thereof.
10. The method of claim 1 , wherein the individual has osteomyelitis.
11. The method of claim 1 , wherein the fetal support tissue product is aseptically processed or terminally sterilized.
12. The method of claim 1 , wherein the fetal support tissue product is from human, non-human primate, cow, or pig.
13. The method of claim 1 , wherein the fetal support tissue product further comprises Wharton's Jelly.
14. The method of claim 1 , wherein the fetal support tissue product is substantially free of blood, lacks an umbilical cord vein, or lacks umbilical cord arteries.
15. The method of claim 1 , wherein the complex wound is a chronic wound.
16. The method of claim 1 , wherein the complex wound is the result of an injury, surgery, a burn, radiation or a combination thereof.
17. The method of claim 1 , wherein the complex wound is associated with an infection.
18. The method of claim 1 , wherein the fetal support tissue product comprises biologically active HC-HA/PTX3.
19. The method of claim 1 , wherein the fetal support tissue product is formulated as a sheet.
20. The method of claim 19 , wherein the fetal support tissue product sheet is administered to the complex wound such that it covers less than the whole area of the complex wound.
21. The method of claim 19 , wherein the fetal support tissue product sheet is placed along the wound borders to progress the wound to complete healing.
22. The method of claim 19 , wherein the fetal support tissue product sheet is absorbed by the complex wound.
23. The method of claim 22 , wherein the fetal support tissue product sheet is absorbed by the complex wound within 4 weeks after the first application of the fetal support tissue product.
24. The method of claim 1 , wherein the complex wound is re-keratinized.
25. The method of claim 1 , wherein the complex wound is re-epithelialized after 1 or 2 applications of the fetal support tissue product.
26. The method of claim 1 , wherein the complex wound is revascularized after 1 or 2 applications of the fetal support tissue product.